Both in Pharmaceuticals
Arcutis Biotherapeutics vs Enliven Therapeutics
Over the past year ARQT returned +43.7% and ELVN returned +129.1%; their daily moves had a correlation of 0.18.
ARQT +43.7% ELVN +129.1%Growth of $1, one year, split-adjusted
| Metric | ARQT | ELVN |
|---|---|---|
| Price | $26.75 | $46.51 |
| Market cap | $3.36B | $3.41B |
| Today | −2.12% | +1.09% |
| 1 month | +12.5% | −19.6% |
| 6 months | +25.4% | +27.1% |
| Year to date | −7.9% | +202.0% |
| 1 year | +52.2% | +132.4% |
| Revenue growth (YoY) | +59.3% | — |
| Gross margin | 91.6% | — |
| Net margin | 11.6% | — |
| P/E (TTM) | 117.9× | — |
| Price / sales | 7.2× | — |
| Net cash | $129.7M | $895.2M |
| Dividend yield | — | — |
| Volatility (60d) | 46.8% | 39.6% |
| Short % of float | 16.3% | 14.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).